Video
Video
06/14/2024
Michael J. Bloch, MD
In this video, Michael J. Bloch, MD, discusses any cardiovascular benefits to the use of estrogen-free oral contraceptives in women, including a recently published study on the association of menstrual...
06/14/2024
Video
Video
06/14/2024
Michael J. Bloch, MD
In this video, Michael J. Bloch, MD, discusses any cardiovascular benefits to the use of estrogen-free oral contraceptives in women, including a recently published study on the association of menstrual...
06/14/2024
Video
Video
06/14/2024
Michael J. Bloch, MD
In this video, Michael J. Bloch, MD, discusses any cardiovascular benefits to the use of estrogen-free oral contraceptives in women, including a recently published study on the association of menstrual...
06/14/2024
Video
Video
06/11/2024

Kathryn Kreider, DNP, APRN, FAANP, FNP-BC

Kathryn Kreider, DNP, APRN, FAANP, FN...
In this video, Kathryn Kreider, DNP, APRN, FAANP, FNP-BC, speaks about the use of glucagon-like peptide-1 (GLP-1s) agonists in patients with type 2 diabetes (T2D) and obesity, including how the medication...
06/11/2024
Video
Video
06/11/2024

Kathryn Kreider, DNP, APRN, FAANP, FNP-BC

Kathryn Kreider, DNP, APRN, FAANP, FN...
In this video, Kathryn Kreider, DNP, APRN, FAANP, FNP-BC, speaks about the use of glucagon-like peptide-1 (GLP-1s) agonists in patients with type 2 diabetes (T2D) and obesity, including how the medication...
06/11/2024
Video
Video
06/11/2024

Kathryn Kreider, DNP, APRN, FAANP, FNP-BC

Kathryn Kreider, DNP, APRN, FAANP, FN...
In this video, Kathryn Kreider, DNP, APRN, FAANP, FNP-BC, speaks about the use of glucagon-like peptide-1 (GLP-1s) agonists in patients with type 2 diabetes (T2D) and obesity, including how the medication...
06/11/2024
Video
Video
06/11/2024

Kathryn Kreider, DNP, APRN, FAANP, FNP-BC

Kathryn Kreider, DNP, APRN, FAANP, FN...
In this video, Kathryn Kreider, DNP, APRN, FAANP, FNP-BC, speaks about the use of glucagon-like peptide-1 (GLP-1s) agonists in patients with type 2 diabetes (T2D) and obesity, including how the medication...
06/11/2024
Video
Video
06/11/2024

Kathryn Kreider, DNP, APRN, FAANP, FNP-BC

Kathryn Kreider, DNP, APRN, FAANP, FN...
In this video, Kathryn Kreider, DNP, APRN, FAANP, FNP-BC, speaks about the use of glucagon-like peptide-1 (GLP-1s) agonists in patients with type 2 diabetes (T2D) and obesity, including how the medication...
06/11/2024
Video
Video
06/11/2024

Kathryn Kreider, DNP, APRN, FAANP, FNP-BC

Kathryn Kreider, DNP, APRN, FAANP, FN...
In this video, Kathryn Kreider, DNP, APRN, FAANP, FNP-BC, speaks about the use of glucagon-like peptide-1 (GLP-1s) agonists in patients with type 2 diabetes (T2D) and obesity, including how the medication...
06/11/2024
Video
Video
06/07/2024

Sarah Lawson, MD

Sarah Lawson, MD
Although most of the literature on home insulin pump use and safety involves adult users, Sarah Lawson, MD, and her team set out to determine the level of safety involving home insulin pumps in children and...
06/07/2024